文献速递消化道肿瘤放疗

放射治疗对直肠癌等待观察方案患者肛门直肠功能的影响

Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme.
PubMed 文献 · Radiother Oncol · 2018-12-21

本研究纳入33例接受放化疗后等待观察方案的直肠癌患者,随访至少2年,通过肛门直肠测压和患者报告结局评估肛门直肠功能,并分析放疗剂量-体积效应。中位随访38个月后,33.3%的患者报告严重LARS,最常见的症状为排便聚集和便急。观察到肛门括约肌复合体剂量较高时Vaizey和LARS评分有升高趋势,但无统计学显著性。

要点

  • 33例直肠癌等待观察患者中,33.3%报告严重LARS,平均LARS评分23.4±11.3,平均Vaizey评分4.3±4.1。
  • 最常见的主诉为排便聚集和便急。
  • 肛门括约肌复合体剂量较高时Vaizey和LARS评分有升高趋势,但未达统计学显著。

核心结论

  • 这是首项专门研究直肠癌患者放疗对肛门直肠功能晚期剂量-体积效应的研究。
  • 三分之一患者存在严重LARS,最常见主诉为排便聚集和便急。
  • 观察到肛门括约肌复合体放疗剂量较高后长期肛门直肠功能有变差趋势,但需更大规模评估。
  • 未来努力减少括约肌剂量可能降低放疗对肛门直肠功能的影响。

研究设计与样本

  • 纳入33例原发性直肠癌患者,接受放化疗及等待观察方案,最低随访2年。
  • 采用肛门直肠测压和患者报告结局(Vaizey和LARS评分)评估肛门直肠功能。
  • 计算直肠和肛门括约肌复合体的剂量-体积直方图,并分析剂量-体积参数与肛门直肠功能的关系。

主要发现

  • 直肠Dmean为50.5 Gy,肛门括约肌复合体Dmean为44.7 Gy。
  • 中位随访38个月(范围23-116个月)后,33.3%的患者报告严重LARS。
  • 平均LARS评分为23.4±11.3,平均Vaizey评分为4.3±4.1。
  • 最常见的主诉为排便聚集和便急。
  • 肛门括约肌复合体剂量较高后Vaizey和LARS评分有升高趋势,但这些关联无统计学显著性。

局限性

  • 肛门括约肌复合体剂量较高与Vaizey和LARS评分升高的关联无统计学显著性。
  • 肛门括约肌复合体剂量较高后长期肛门直肠功能变差的趋势需在更大规模上评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To assess the long-term anorectal function in rectal cancer patients following a watch-and-wait policy after chemoradiotherapy and to investigate the dose-volume effects of radiotherapy on the anorectal function. METHODS AND MATERIALS: Thirty-three patients with primary rectal cancer who were treated with chemoradiotherapy and a watch-and-wait policy with minimum follow-up of 2 years were included. We assessed the anorectal function using anorectal manometry and patient reported outcomes (Vaizey and LARS score). Dose-volume histograms were calculated for the rectum and anal sphincter complex, and associations between the dose-volume parameters and anorectal function were assessed. RESULTS: Dmean to the rectum and anal sphincter complex was 50.5 Gy and 44.7 Gy, respectively. After a median follow-up of 38 (range 23-116) months, 33.3% of the patients reported major LARS. Mean LARS score was 23.4 ± 11.3 and mean Vaizey score was 4.3 ± 4.1. The most frequent complaints were clustering of defaecation and faecal urgency. Trends towards a higher Vaizey and LARS score after higher anal sphincter complex dose were observed, although these associations were not statistically significant. CONCLUSIONS: This is the first study to investigate the late dose-volume effects of radiotherapy specifically on the anorectal function in rectal cancer patients. One-third of the patients had major LARS and the most frequent reported complaints were clustering and faecal urgency. Additionally, we observed trends towards worse long-term anorectal function after higher anal sphincter complex radiotherapy dose. However, this should be evaluated on a larger scale. Future efforts to minimise the dose to the sphincters could possibly reduce the impact of radiotherapy on the anorectal function.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. van der Sande ME, Hupkens BJP, Berbée M, et al. Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme. Radiother Oncol. 2018. PMID: 30825973. doi:10.1016/j.radonc.2018.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。